Worldwide Epigenetics Market Analysis & Forecast to 2019

Press Release   •   Sep 30, 2014 15:31 EDT

Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), Research Area (Developmental Biology, Oncology) & by End User – Global Forecast to 2019

In this report, the global epigenetics market is segmented on the basis of products, research areas, and end users. The product segments of the epigenetics market included in this report are enzymes, instruments & consumables, kits, and reagents. The subsegments of the enzymes product segment are DNA-modifying enzymes (DNA ligases, DNA polymerases and other DNA-modifying enzymes); protein-modifying enzymes (acetylases, methyltransferases and other protein-modifying enzymes); and RNA-modifying enzymes (reverse transcriptases, RNA ligases, and other RNA-modifying enzymes). The subsegments of the instruments & consumables product segment are mass spectrometers; next-generation sequencers; qPCRs; sonicators; and other epigenetics instruments & consumables. The subsegments of the kits product segment are bisulfite conversion kits; ChIP-seq kits; RNA sequencing kits; whole genome amplification kits; 5-hmC & 5-mC analysis kits; and other epigenetics kits. The subsegments of the reagents product segment are antibodies; buffers; histones; magnetic beads; primers; and other epigenetics reagents.

Epigenetics has applications in a large number of research areas. On the basis of research areas, the report is segmented into developmental biology, drug discovery, oncology, and other epigenetics research areas. On the basis of end users, the global epigenetics market  report is segmented into academic research institutes, biotechnology and pharmaceutical companies, and contract research organizations. The geographic segments included in this report are Asia, Europe, North America, and Rest of the World.

The key driver for this market is growth in cancer prevalence. The rising incidence of this disease has prompted increased research interest and funding for research. Furthermore, as epigenetics has shown potential for the development of new therapeutic products for diseases like cancer, partnerships between biotechnology and pharmaceutical companies for the development of epigenetics-based therapeutics products have increased, leading to intensified R&D activities in this field; all factors that will aid the growth of the global epigenetics market.

Complete report available @ http://www.lifescienceindustryresearch.com/epigenetics-technology-market-epigenomics-dna-methylation-histone-modifications-rna-interference-cancer-therapeutics-personalized-medicine-2012-2017.html

In this report, a combination of bottom-up and top-down approaches were used to calculate market sizes and growth rates. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. Estimates of their epigenetics segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine percentage shares of each subsegment and the relative differences in the growth rates.

The report provides qualitative insights about key market shares, growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each subsegment and identifies segments poised for rapid growth in each of geographic segment. The report also includes company profiles of market leaders. These company profiles include financial performances, product portfolios, and market developments for each company. The report also provides a competitive landscape of the epigenetics market. The competitive landscape covers growth strategies adopted by industry players over the last three years. It also includes analysis of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.
The report provides insights on the following:

  • Product Development/Innovation: Product portfolios of the top players in the epigenetics market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the epigenetics market
  • Competitive Assessment: In-depth assessment of the market shares, strategies, geographic and business segments, and product portfolios of the leading players in the epigenetics market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various epigenetics products across geographies
  • Market Diversification: Exhaustive information about new products and services, recent developments, and investments in the epigenetics market

Inquire For Discount (Single User Report Price US $4650) @


Table of Contents:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Epigenetics Market, By Product

8 Epigenetics Market, By Research Areas

9 Market, By End User

10 Geographic Analysis

11 Competitive Landscape

12 Company Profiles
12.1 Introduction
12.2 Abcam
12.3 Illumina
12.4 New England Biolabs
12.5 Sigma-Aldrich Corporation
12.6 Thermo Fisher Scientific
12.7 Active Motif
12.8 Diagenode
12.9 Merck
12.10 Qiagen
12.11 Zymo Research

Purchase a copy of this report (Single User Report Price US $4650) @


For other business research / market intelligence report on the ‘Medical Devices’ market, contact sales@lifescienceindustryresearch.com  / Call +1 888 391 5441.